Poderá a Fotobiomodulação Aguda Melhorar o Equilíbrio e a Cognição em Indivíduos com Ataxia: um Ensaio de Viabilidade Piloto Controlado Randomizado com Placebo.
Pode a Fotobiomodulação Aguda Melhorar o Equilíbrio e a Cognição em Indivíduos com Ataxia: um Ensaio de Viabilidade Controlado Randomizado com Placebo.
Cerebellar ataxias cause progressive impairments in balance, gait coordination, motor timing, and cognitive functions such as attention and executive control (Buckner, 2013; Salmi et al., 2010; Timmann & Daum, 2007). These symptoms substantially reduce independence and quality of life, and current treatments remain limited. There is an urgent need for safe, low-burden interventions that can support everyday functioning and potentially enhance compensatory neural processes.
Transcranial photobiomodulation (tPBM) uses red and near-infrared light (600-1100 nm) to modulate mitochondrial cytochrome-c oxidase, increasing ATP production, reducing oxidative stress, and improving cerebral blood flow (Hamblin, 2016; Salehpour et al., 2019). Several studies show that tPBM can acutely improve cognitive performance and motor control in both healthy adults and clinical groups (Barrett & Gonzalez-Lima, 2013; Chan et al., 2019; Henderson & Morries, 2017). A growing neurobiological literature suggests that light can penetrate posterior cortical areas sufficiently to modulate networks involving cerebellar-cortical loops (Jagdeo et al., 2012).
Importantly for ataxia, preliminary work shows that tPBM may acutely improve balance stability and gait metrics in older adults and patients with neurological conditions (Moro et al., 2022; Shin et al., 2021). In our own laboratory, we have observed immediate improvements in sway range and cognitive control in older adults after a 24-minute tPBM session applied over midline and posterior scalp regions. These medium to large size effects are consistent with enhanced sensorimotor integration and improved control of attention in distracting environments.
Given that individuals with cerebellar ataxia experience both motor incoordination and difficulties in maintaining cognitive stability under distracting conditions, tPBM is a promising non-pharmacological intervention worth preliminary investigation.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Jonathan J Sinclair, DSc
- Número de telefone: +44787565153
- E-mail: jksinclair@lancashire.ac.uk
Locais de estudo
-
-
Lancashire
-
Preston, Lancashire, Reino Unido, PR1 2HE
- University of Central Lancashire
-
Contato:
- Sinclair
- Número de telefone: 07875651533
- E-mail: jksinclair@lancashire.ac.uk
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age 18-70 years (inclusive)
- Diagnosis of ataxia
- Able to walk independently for at least 5 minutes, with or without an assistive device
- Able to stand safely for balance testing, with or without an assistive device
- Hemodynamically stable (stable blood pressure and heart rate at rest)
- On a stable medication regimen for ≥4 weeks prior to enrolment
- Sufficient vision and hearing (with usual aids if required) to complete balance and cognitive assessments
- Able to complete study questionnaires and cognitive tasks (with assistance for reading/writing if required)
- Able and willing to provide written informed consent
Exclusion Criteria:
- Current or past history of head injury
- Use of medications acting on the central nervous system
- Active skin conditions on the forehead or scalp
- Any other major neurological disorder that could independently affect balance or cognition
- Ongoing brain stimulation therapy
- History of migraines
- Sensitive skin, allergies
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Comparador de Placebo: Sham Comparator: Sham photobiomodulation
Sham photobiomodulation. The sham device will follow the same protocol but without active light emission. |
The sham device will follow the same protocol but without active light emission. |
|
Experimental: Photobiomodulation
Acute photobiomodulation Twenty-four-minute photobiomodulation stimulation (twelve minutes at 670 nm followed by twelve minutes at 810 nm). |
Photobiomodulation |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
n-1-back (deviation)
Prazo: Baseline
|
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier. |
Baseline
|
|
n-1-back (deviation)
Prazo: 1 hour
|
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier. |
1 hour
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
n-2-back (deviation)
Prazo: Baseline
|
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier. |
Baseline
|
|
n-2-back (deviation)
Prazo: 1 hour
|
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier. |
1 hour
|
|
n-1-back (post-deviation)
Prazo: Baseline
|
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier. |
Baseline
|
|
n-1-back (post-deviation)
Prazo: 1 hour
|
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier. |
1 hour
|
|
n-2-back (post-deviation)
Prazo: Baseline
|
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier. |
Baseline
|
|
n-2-back (post-deviation)
Prazo: 1 hour
|
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier. |
1 hour
|
|
n-1-back (post-target)
Prazo: Baseline
|
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier. |
Baseline
|
|
n-1-back (post-target)
Prazo: 1 hour
|
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier. |
1 hour
|
|
n-2-back (post-target)
Prazo: Baseline
|
The n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier. |
Baseline
|
|
n-2-back (post-target)
Prazo: 1 hour
|
The n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier. |
1 hour
|
|
n-1-back (load)
Prazo: Baseline
|
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back. |
Baseline
|
|
n-1-back (load)
Prazo: 1 hour
|
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back. |
1 hour
|
|
n-2-back (post-load)
Prazo: Baseline
|
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task. |
Baseline
|
|
n-2-back (post-load)
Prazo: 1 hour
|
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task. |
1 hour
|
|
Coop-Wonka chart
Prazo: Baseline
|
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing. |
Baseline
|
|
Coop-Wonka chart
Prazo: 1 hour
|
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing. |
1 hour
|
|
Beck Depression Inventory
Prazo: Baseline
|
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible. |
Baseline
|
|
Beck Depression Inventory
Prazo: 1 hour
|
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible. |
1 hour
|
|
Pittsburgh Sleep Quality Index
Prazo: Baseline
|
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality. |
Baseline
|
|
Pittsburgh Sleep Quality Index
Prazo: 1 hour
|
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality. |
1 hour
|
|
State Trait Anxiety Inventory
Prazo: Baseline
|
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety. |
Baseline
|
|
State Trait Anxiety Inventory
Prazo: 1 hour
|
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety. |
1 hour
|
|
Insomnia Severity Index
Prazo: Baseline
|
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28. |
Baseline
|
|
Insomnia Severity Index
Prazo: 1 hour
|
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28. |
1 hour
|
|
Epworth Sleepiness Scale
Prazo: Baseline
|
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24. |
Baseline
|
|
Epworth Sleepiness Scale
Prazo: 1 hour
|
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24. |
1 hour
|
|
Everyday Memory Errors Questionnaire
Prazo: Baseline
|
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life. It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties. |
Baseline
|
|
Everyday Memory Errors Questionnaire
Prazo: 1 hour
|
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life. It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties. |
1 hour
|
|
Falls Efficacy
Prazo: Baseline
|
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling. It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy. |
Baseline
|
|
Falls Efficacy
Prazo: 1 hour
|
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling. It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy. |
1 hour
|
|
Anterior-posterior balance
Prazo: Baseline
|
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task. |
Baseline
|
|
Anterior-posterior balance
Prazo: 1 hour
|
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task. |
1 hour
|
|
Medio-lateral balance
Prazo: Baseline
|
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task. |
Baseline
|
|
Medio-lateral balance
Prazo: 1 hour
|
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task. |
1 hour
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- PMB Ataxia pilot feasibility s
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .